BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dimachkie MM, Barohn RJ. Guillain-Barré syndrome and variants. Neurol Clin. 2013;31:491-510. [PMID: 23642721 DOI: 10.1016/j.ncl.2013.01.005] [Cited by in Crossref: 191] [Cited by in F6Publishing: 202] [Article Influence: 19.1] [Reference Citation Analysis]
Number Citing Articles
1 Pimentel V, Luchsinger VW, Carvalho GL, Alcará AM, Esper NB, Marinowic D, Zanirati G, da Costa JC. Guillain-Barré syndrome associated with COVID-19: A systematic review. Brain Behav Immun Health 2023;:100578. [PMID: 36686624 DOI: 10.1016/j.bbih.2022.100578] [Reference Citation Analysis]
2 Wachira VK, Farinasso CM, Silva RB, Peixoto HM, de Oliveira MRF. Incidence of Guillain-Barré syndrome in the world between 1985 and 2020: A systematic review. Global Epidemiology 2023. [DOI: 10.1016/j.gloepi.2023.100098] [Reference Citation Analysis]
3 Ogbebor O, Tariq S, Jaber T, Super J, Bhanot N, Rana S, Malik K. Neurological Emergencies in the Intensive Care Unit. Critical Care Nursing Quarterly 2023;46:17-34. [DOI: 10.1097/cnq.0000000000000435] [Reference Citation Analysis]
4 Khan Z, Ahmad U, Ualiyeva D, Amissah OB, Khan A, Noor Z, Zaman N. Guillain-Barre syndrome: An autoimmune disorder post-COVID-19 vaccination? Clinical Immunology Communications 2022;2:1-5. [DOI: 10.1016/j.clicom.2021.12.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
5 Luan H, Zhang P, Zhen M, Li M, Wang X, Xu J. Recurrent Guillain-Barré syndrome presenting as pharyngeal-cervical-brachial variant with three species of ganglioside antibodies:case report. BMC Neurol 2022;22:441. [PMID: 36443698 DOI: 10.1186/s12883-022-02955-0] [Reference Citation Analysis]
6 Chohan S, Chohan A. Recurrence of a Rare Subtype of Guillain-Barré Syndrome Following a Second Dose of the Shingles Vaccine. Cureus 2022. [DOI: 10.7759/cureus.30717] [Reference Citation Analysis]
7 Al-Ameen O, Faisal M, Mustafa S, Alhatou M. Atypical Guillain-Barre syndrome with T6 sensory level. Clin Case Rep 2022;10:e6414. [PMID: 36245439 DOI: 10.1002/ccr3.6414] [Reference Citation Analysis]
8 Boutros N, Trikamji B. A rare overlap between Miller Fisher syndrome and pure motor Guillain-Barre syndrome. Acta Neurol Belg 2022. [PMID: 36201115 DOI: 10.1007/s13760-022-02111-y] [Reference Citation Analysis]
9 Bhatia VD, Khant PB, Vyshnavee I, Shiyaf M, Thunga G, Gorthi SP, Kunhikatta V. Identification of factors affecting outcomes in patients with Guillain Barre syndrome. Med Pharm Rep 2022;95:400-9. [PMID: 36506607 DOI: 10.15386/mpr-2184] [Reference Citation Analysis]
10 Attia R, Stolowy N, Dupessey F, Mairot K, Denis D, David T. Œdème papillaire et syndrome de Guillain-Barré : à propos d’un cas. Journal Français d'Ophtalmologie 2022;45:e361-e364. [DOI: 10.1016/j.jfo.2022.01.017] [Reference Citation Analysis]
11 Stein RA. Campylobacter jejuni and Postinfectious Autoimmune Diseases: A Proof of Concept in Glycobiology. ACS Infect Dis 2022. [PMID: 36137262 DOI: 10.1021/acsinfecdis.2c00397] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
12 Zhao M, Gu Y, Zhao J, Li N. AntiGQ1b antibody positive with MFS/GBS overlapped syndrome with diplopia and hemiplegia onset: Case report and retrospective analysis. Medicine (Baltimore) 2022;101:e30584. [PMID: 36123885 DOI: 10.1097/MD.0000000000030584] [Reference Citation Analysis]
13 Tondo G, Virgilio E, Naldi A, Bianchi A, Comi C. Safety of COVID-19 Vaccines: Spotlight on Neurological Complications. Life 2022;12:1338. [DOI: 10.3390/life12091338] [Reference Citation Analysis]
14 Shekhar S, Harisingani A, Gupta N. Abdominal Pain Followed by Altered Mental Status: A Rare Presentation of Guillain Barré Syndrome. Cureus 2022. [DOI: 10.7759/cureus.27550] [Reference Citation Analysis]
15 Girma B, Farkas DK, Laugesen K, Skajaa N, Henderson VW, Boffetta P, Sørensen HT. Cancer Diagnosis and Prognosis After Guillain-Barré Syndrome: A Population-Based Cohort Study. Clin Epidemiol 2022;14:871-8. [PMID: 35898330 DOI: 10.2147/CLEP.S369908] [Reference Citation Analysis]
16 Keh RYS, Shah S, Lilleker JB, Lavin T, Morrow J, Carr AS, Lunn MP. Pragmatic guide to peripheral nerve disease and the role of clinical biomarkers. Pract Neurol. [DOI: 10.1136/pn-2022-003438] [Reference Citation Analysis]
17 Zarifkar P, Peinkhofer C, Benros ME, Kondziella D. Frequency of Neurological Diseases After COVID-19, Influenza A/B and Bacterial Pneumonia. Front Neurol 2022;13:904796. [DOI: 10.3389/fneur.2022.904796] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
18 Mustafa B, Yousaf Q, Aslam A, Farooq M, Ashraf A, Ehsan M, Zahid A, Athar F. Rarest of the rare: a case of pharyngeal-cervical-brachial variant of Guillain-Barré syndrome presenting with a demyelinating neuropathy. Int J Neurosci 2022;:1-3. [PMID: 35658783 DOI: 10.1080/00207454.2022.2084090] [Reference Citation Analysis]
19 Kim S, Han HJ, Shin HY, Kim SW. Old age and multiple comorbidity are associated with delayed diagnosis of Guillain-Barre syndrome. Sci Rep 2022;12:9913. [PMID: 35705625 DOI: 10.1038/s41598-022-14184-z] [Reference Citation Analysis]
20 Patel PN, Schloss MG, Sharma K, Dulai P. A Dorsal Epidural Herniated Disc Fragment Initially Presenting as Guillain-Barré Syndrome. Cureus. [DOI: 10.7759/cureus.25719] [Reference Citation Analysis]
21 Hati A, Chakraborty U, Chandra A, Biswas P. Hypokalaemia with Guillain-Barré syndrome: a diagnostic and therapeutic challenge. BMJ Case Rep 2022;15:e249473. [DOI: 10.1136/bcr-2022-249473] [Reference Citation Analysis]
22 López-hernández JC, Galnares-olalde JA, Jorge de Saráchaga A, Briseño-godínez ME, Pérez-valdez E, May-mas RN, Arista-ramírez JL, Bazán-rodríguez L, León-manriquez E, Burgos-centeno J, Vargas-cañas ES. Very low peroneal nerve compound muscle action potential amplitude predicts poor outcome in patients with Guillain-Barré syndrome: a prospective cohort. Neurol Sci 2022;43:3923-3928. [DOI: 10.1007/s10072-021-05834-7] [Reference Citation Analysis]
23 Covino M, Romozzi M, Simeoni B, Di Paolantonio A, Sabatelli M, Franceschi F, Luigetti M. Guillain-Barré syndrome from an emergency department view: how to better predict the outcome? Neurol Res 2022;:1-5. [PMID: 35580194 DOI: 10.1080/01616412.2022.2075661] [Reference Citation Analysis]
24 Patel P, Shah D, Jani C, Shah J, Jani R, Kelaiya A, Pandya J, Singh H, Al Omari O, Roy D, Behlau I, Parikh A. Outcomes of patients presenting with Guillain-Barre Syndrome at a tertiary care center in India. BMC Neurol 2022;22:151. [PMID: 35459157 DOI: 10.1186/s12883-022-02676-4] [Reference Citation Analysis]
25 Álvarez A, Alonso M, Ospino D, Escamilla V. Síndrome de Guillain-Barré de presentación inusual y ataxia cerebelosa asociado a COVID-19 en paciente pediátrico. Neurología Argentina 2022;14:132-134. [DOI: 10.1016/j.neuarg.2021.08.009] [Reference Citation Analysis]
26 Arriaga-nieto L, Hernández-bautista PF, Vallejos-parás A, Grajales-muñiz C, Rojas-mendoza T, Cabrera-gaytán DA, Grijalva-otero I, Cacho-díaz B, Jaimes-betancourt L, Padilla-velazquez R, Valle-alvarado G, Perez-andrade Y, Ovalle-luna OD, Rivera-mahey M. Predict the incidence of Guillain Barré Syndrome and arbovirus infection in Mexico, 2014–2019. PLOS Glob Public Health 2022;2:e0000137. [DOI: 10.1371/journal.pgph.0000137] [Reference Citation Analysis]
27 Akgun Y, Langlie J, Huberman MA, Wu Y. Therapeutic plasma exchange in a patient with acute motor axonal neuropathy subtype of Guillain-Barre syndrome and systemic lupus erythematosus. J Clin Apher 2022. [PMID: 35218244 DOI: 10.1002/jca.21977] [Reference Citation Analysis]
28 Chaweekulrat P, Sanmaneechai O. Prognostic model for time to achieve independent walking in children with Guillain-Barré syndrome. Pediatr Res 2022. [PMID: 35169277 DOI: 10.1038/s41390-021-01919-3] [Reference Citation Analysis]
29 Javed A. Neurological Associations of SARS-CoV-2 Infection: A Systematic Review. CNS Neurol Disord Drug Targets 2022;21:246-58. [PMID: 33593267 DOI: 10.2174/1871527320666210216121211] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 10.0] [Reference Citation Analysis]
30 Thomas NJ, Shekarchian S, Bock MA, Holmes BB, Geha RM, Shah MP. A striking dichotomy. Journal of Hospital Medicine. [DOI: 10.1002/jhm.2780] [Reference Citation Analysis]
31 Patry RT, Essler L, Andresen S, Quinn FD, Szymanski CM. Low-Dose Exposure to Ganglioside-Mimicking Bacteria Tolerizes Human Macrophages to Guillain-Barré Syndrome-Associated Antigens. mBio 2022;:e0385221. [PMID: 35100875 DOI: 10.1128/mbio.03852-21] [Reference Citation Analysis]
32 Ahmadi M, Rezaei Z, Shirazi FA, Shafiei M. Guillain–Barre syndrome: a prevalent autoimmune disease during the coronavirus disease-2019 pandemic. Reviews in Medical Microbiology 2022;33:e198-e211. [DOI: 10.1097/mrm.0000000000000301] [Reference Citation Analysis]
33 Albin CSW, Zafar SF. Approach to New Onset Weakness. The Acute Neurology Survival Guide 2022. [DOI: 10.1007/978-3-030-75732-8_30] [Reference Citation Analysis]
34 Moscona-Nissan A Sr, López-Hernández JC, Seidman-Sorsby A, Cruz-Zermeño M, Navalón-Calzada A. Pharyngeal-Cervical-Brachial Variant of Guillain-Barré Syndrome. Cureus 2021;13:e18788. [PMID: 34804654 DOI: 10.7759/cureus.18788] [Reference Citation Analysis]
35 Fischer A, Avila J. Guillain-Barré Syndrome Following an Extended-Spectrum Beta-Lactamase Escherichia coli Urinary Tract Infection: A Case Report. Cureus 2021;13:e19673. [PMID: 34804758 DOI: 10.7759/cureus.19673] [Reference Citation Analysis]
36 Eslamian F, Taleschian-Tabrizi N, Izadseresht B, Shakouri SK, Gholian S, Rahbar M. Electrophysiologic findings in patients with COVID-19 and quadriparesia in the northwest of Iran, A case series study and literature review. Caspian J Intern Med 2021;12:S451-9. [PMID: 34760104 DOI: 10.22088/cjim.12.0.451] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
37 Stojanov A, Basta I, Berisavac I, Stojiljkovic-Tamas O, Bozovic I, Arsenijevic M, Palibrk A, Peric S. Responsiveness of 2 Different Ability Outcome Measures in Guillain-Barré Syndrome. Neurologist 2021;26:244-7. [PMID: 34734901 DOI: 10.1097/NRL.0000000000000341] [Reference Citation Analysis]
38 Szewczyk AK, Skrobas U, Jamroz-Wiśniewska A, Mitosek-Szewczyk K, Rejdak K. Facial Diplegia-Complication or Manifestation of SARS-CoV-2 Infection? A Case Report and Systemic Literature Review. Healthcare (Basel) 2021;9:1492. [PMID: 34828542 DOI: 10.3390/healthcare9111492] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
39 Morehouse ZP, Paulus A, Jasti SA, Bing X. A Rare Variant of Guillain-Barre Syndrome Following Ad26.COV2.S Vaccination. Cureus 2021;13:e18153. [PMID: 34703690 DOI: 10.7759/cureus.18153] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
40 Tagaloa E, Venter F, Liang L, Bhaika J, Aguirre D, Patel J, Nasrawi F. A Rare Case of Guillain-Barré Syndrome With Severe Pandysautonomia. J Investig Med High Impact Case Rep 2021;9:23247096211019558. [PMID: 34027705 DOI: 10.1177/23247096211019558] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
41 Sri Dewi Untari NK, Kusumastuti K, Suryokusumo G, Sudiana IK. Characteristics of Guillain-Barre Syndrome Patient Underwent Hyperbaric Oxygen Therapy at Lakesla 2016–2019. Open Access Maced J Med Sci 2021;9:1174-1179. [DOI: 10.3889/oamjms.2021.6679] [Reference Citation Analysis]
42 Rossetti A, Gheihman G, O'Hare M, Kosowsky JM. Guillain-Barré Syndrome Presenting as Facial Diplegia after COVID-19 Vaccination: A Case Report. J Emerg Med 2021;61:e141-5. [PMID: 34538679 DOI: 10.1016/j.jemermed.2021.07.062] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 7.0] [Reference Citation Analysis]
43 Laudanski K, Yakhkind A, Restrepo M, Draham L, Lang AE. Guillain–Barré Syndrome in COVID-19—The Potential Role of NCAM-1 and Immunotherapy. BioMed 2021;1:80-92. [DOI: 10.3390/biomed1010006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
44 Luitel P, Neupane N, Adhikari N, Paudel S, Gajurel BP, Karn R, Rajbhandari R, Gautam N, Shrestha A, Ojha R. Paraparetic Guillain-Barre syndrome: An uncommon diagnosis of acute flaccid paralysis of the lower limbs. Clin Case Rep 2021;9:e04767. [PMID: 34484783 DOI: 10.1002/ccr3.4767] [Reference Citation Analysis]
45 Svačina MK, Lehmann HC. Akute Polyradikuloneuritis: das Guillain-Barré-Syndrom. Neurologie up2date 2021;04:271-279. [DOI: 10.1055/a-1163-6617] [Reference Citation Analysis]
46 Jain E, Pandav K, Regmi P, Michel G, Altshuler I. Facial Diplegia: A Rare, Atypical Variant of Guillain-Barré Syndrome and Ad26.COV2.S Vaccine. Cureus 2021;13:e16612. [PMID: 34447646 DOI: 10.7759/cureus.16612] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
47 Baj J, Forma A, Flieger W, Morawska I, Michalski A, Buszewicz G, Sitarz E, Portincasa P, Garruti G, Flieger M, Teresiński G. Helicobacter pylori Infection and Extragastric Diseases-A Focus on the Central Nervous System. Cells 2021;10:2191. [PMID: 34571840 DOI: 10.3390/cells10092191] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
48 Puentes D, Teijelo D, Stiep TS, Mannava S, Margolesky J. Takotsubo Cardiomyopathy as a Manifestation of Dysautonomia in Guillain-Barré Syndrome: A Case Series and Review of the Literature. Cureus 2021;13:e16069. [PMID: 34345553 DOI: 10.7759/cureus.16069] [Reference Citation Analysis]
49 Frank CHM, Almeida TVR, Marques EA, de Sousa Monteiro Q, Feitoza PVS, Borba MGS, Vasconcelos HL, de Souza Bastos M, Lacerda MVG. Guillain-Barré Syndrome Associated with SARS-CoV-2 Infection in a Pediatric Patient. J Trop Pediatr 2021;67:fmaa044. [PMID: 32653906 DOI: 10.1093/tropej/fmaa044] [Cited by in Crossref: 39] [Cited by in F6Publishing: 42] [Article Influence: 19.5] [Reference Citation Analysis]
50 Sardar S, Sasi S, Menik Arachchige S, Zahid M, Melikyan G. Isolated facial diplegia: A rare presentation of Guillain-Barre syndrome. Clin Case Rep 2021;9:e04473. [PMID: 34322247 DOI: 10.1002/ccr3.4473] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
51 Yaranagula SD, Koduri VKC. Spectrum of Acute Neuropathy Associated With Covid-19: A Clinical and Electrophysiological Study of 13 Patients From a Single Center. Int J Infect Dis 2021;110:314-9. [PMID: 34333121 DOI: 10.1016/j.ijid.2021.07.066] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
52 Haidary AM, Noor S, Hamed E, Baryali T, Rahmani S, Ahmad M, Erfani F, Azimi H, Habib HUR, Tahiri GA, Saadaat R, Ibrahimkhil AS, Esmat E, Malakzai HA. Acute motor-sensory axonal polyneuropathy variant of Guillain-Barre syndrome complicating the recovery phase of coronavirus disease 2019 infection: a case report. J Med Case Rep 2021;15:379. [PMID: 34271989 DOI: 10.1186/s13256-021-02988-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
53 Alanazy MH, Bakry SS, Alqahtani A, AlAkeel NS, Alazwary N, Osman AM, Mustafa RA, Al-Harbi TM, Abdulmana SO, Amper AC, Aldughaythir Y, Ali AS, Makkawi S, Maglan A, Alamoudi L, Alsulaiman F, Alabdali M, AlShareef AA, Abuzinadah AR, Bamaga AK. Clinical features and outcome of Guillain-Barre syndrome in Saudi Arabia: a multicenter, retrospective study. BMC Neurol 2021;21:275. [PMID: 34253174 DOI: 10.1186/s12883-021-02314-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
54 Shang P, Zhu M, Wang Y, Zheng X, Wu X, Zhu J, Feng J, Zhang H. Axonal variants of Guillain–Barré syndrome: an update. J Neurol 2021;268:2402-2419. [DOI: 10.1007/s00415-020-09742-2] [Cited by in Crossref: 20] [Cited by in F6Publishing: 1] [Article Influence: 10.0] [Reference Citation Analysis]
55 Pathikonda C, Katyal N, Narula N, Govindarajan R. Disease and Patient Characteristics Contributing to Diagnostic Delays in Patients With Guillain-Barré Syndrome. Front Neurol 2021;12:684847. [PMID: 34248826 DOI: 10.3389/fneur.2021.684847] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
56 Aladawi M, Elfil M, Abu-Esheh B, Abu Jazar D, Armouti A, Bayoumi A, Piccione E. Guillain Barre Syndrome as a Complication of COVID-19: A Systematic Review. Can J Neurol Sci 2021;:1-11. [PMID: 33949300 DOI: 10.1017/cjn.2021.102] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 8.5] [Reference Citation Analysis]
57 Shang P, Feng J, Wu W, Zhang HL. Intensive Care and Treatment of Severe Guillain-Barré Syndrome. Front Pharmacol 2021;12:608130. [PMID: 33995011 DOI: 10.3389/fphar.2021.608130] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
58 Yiu AC, Hussain A, Okonkwo UA, Villacorta-Lyew R, McMahon MJ, Blattner M. Guillain-Barre Syndrome Associated With COVID-19 Pneumonia-The First Documented Case in a U.S. Military Intensive Care Unit. Mil Med 2021:usab158. [PMID: 33881526 DOI: 10.1093/milmed/usab158] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
59 He N, Kartiko MC, Selim M. A Case of Pharyngeal-Cervical-Brachial Variant of Guillain-Barré Syndrome With Bilateral Glossopharyngeal Paralysis. Cureus 2021;13:e14551. [PMID: 34017665 DOI: 10.7759/cureus.14551] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
60 Chen YM, Su KY. Acute motor and sensory axonal neuropathy in association with primary Sjögren's syndrome: a case report. BMC Neurol 2021;21:161. [PMID: 33858380 DOI: 10.1186/s12883-021-02190-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
61 Keskin H, Keskin F, Basaslan I, Tan H. Çocuk Yoğun Bakım Ünitesinde Takip Edilen Guillain Barre Sendromu Olguları; 3 Yıllık Deneyim. Sakarya Medical Journal 2021. [DOI: 10.31832/smj.855110] [Reference Citation Analysis]
62 Freiha J, Zoghaib R, Makhoul K, Maalouf N, Riachi N, Chalah MA, Ayache SS, Ahdab R. The value of sensory nerve conduction studies in the diagnosis of Guillain-Barré syndrome. Clin Neurophysiol 2021;132:1157-62. [PMID: 33780722 DOI: 10.1016/j.clinph.2021.02.013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
63 Oliveira R, Ramalho Rocha F, Teodoro T, Oliveira Santos M. Acute non-traumatic tetraparesis - Differential diagnosis. J Clin Neurosci 2021;87:116-24. [PMID: 33863518 DOI: 10.1016/j.jocn.2021.02.024] [Reference Citation Analysis]
64 Papri N, Islam Z, Leonhard SE, Mohammad QD, Endtz HP, Jacobs BC. Guillain-Barré syndrome in low-income and middle-income countries: challenges and prospects. Nat Rev Neurol 2021;17:285-96. [PMID: 33649531 DOI: 10.1038/s41582-021-00467-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
65 Sansone P, Giaccari LG, Aurilio C, Coppolino F, Esposito V, Fiore M, Paladini A, Passavanti MB, Pota V, Pace MC. Post-Infectious Guillain-Barré Syndrome Related to SARS-CoV-2 Infection: A Systematic Review. Life (Basel) 2021;11:167. [PMID: 33670000 DOI: 10.3390/life11020167] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
66 Hammad Seroor Jadah R. Guillain-Barre Syndrome and Miller Fisher Variant in Zika Virus Disease. Current Concepts in Zika Research 2021. [DOI: 10.5772/intechopen.93128] [Reference Citation Analysis]
67 Ryan GA, Cook J, Adams K. Strength and Conditioning for Patients Recovering From Guillain-Barre Syndrome. Strength & Conditioning Journal 2021;43:107-115. [DOI: 10.1519/ssc.0000000000000529] [Reference Citation Analysis]
68 Doxaki C, Papadopoulou E, Maniadaki I, Tsakalis NG, Palikaras K, Vorgia P. Case Report: Intracranial Hypertension Secondary to Guillain-Barre Syndrome. Front Pediatr 2020;8:608695. [PMID: 33553071 DOI: 10.3389/fped.2020.608695] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
69 Waheed W, Tandan R, Bazylewicz M. Nerve root enhancement in Guillain-Barré syndrome. Pract Neurol 2021;21:257-8. [PMID: 33462076 DOI: 10.1136/practneurol-2020-002809] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
70 Mahadevan R, Namboodhri U, Santhosh T. Severity of fatigue among patients with Guillain–Barre syndrome. Int J Health Allied Sci 2021;10:182. [DOI: 10.4103/ijhas.ijhas_246_20] [Reference Citation Analysis]
71 Alvarez A, Alonso M, Ospino D, Escamilla V. Síndrome de Guillain-Barré de presentación inusual y ataxia cerebelosa en paciente pediátrico asociado a COVID-19. Neurología, Neurocirugía y Psiquiatría 2021;49:66-68. [DOI: 10.35366/103353] [Reference Citation Analysis]
72 Hashim NA, Mohamed WS, Emad EM. Neutrophil–lymphocyte ratio and response to plasmapheresis in Guillain–Barré syndrome: a prospective observational study. Egypt J Neurol Psychiatry Neurosurg 2020;56. [DOI: 10.1186/s41983-020-0154-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
73 Park YJ, Suh TK, Kim SH, Baek MJ. Two Different Cases of Simultaneous Bilateral Facial Palsy. J Clin Otolaryngol Head Neck Surg 2020;31:188-195. [DOI: 10.35420/jcohns.2020.31.2.188] [Reference Citation Analysis]
74 Gale A, Sabaretnam S, Lewinsohn A. Guillain-Barré syndrome and COVID-19: association or coincidence. BMJ Case Rep 2020;13:e239241. [PMID: 33257396 DOI: 10.1136/bcr-2020-239241] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
75 Gitlin-Domagalska A, Maciejewska A, Dębowski D. Bowman-Birk Inhibitors: Insights into Family of Multifunctional Proteins and Peptides with Potential Therapeutical Applications. Pharmaceuticals (Basel) 2020;13:E421. [PMID: 33255583 DOI: 10.3390/ph13120421] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
76 Awsare S, Chirikian D, Lui F. Wound Botulism Caused by Botulinum Neurotoxin Type A in a Chronic Parenteral Drug Abuser. Case Rep Neurol 2020;12:422-427. [DOI: 10.1159/000510846] [Reference Citation Analysis]
77 Karaca Sivrikaya S, Günay İ. NÖROMÜSKÜLER BİR HASTALIK: GUİLLAİN BARRÉ SENDROMU VE HEMŞİRELİK. Ordu Üniversitesi Hemşirelik Çalışmaları Dergisi 2020. [DOI: 10.38108/ouhcd.768684] [Reference Citation Analysis]
78 Dhaliwal A, Larson JL, Dhindsa BS, Bhogal N, Rochling FA. Dry Beriberi Manifesting as Acute Inflammatory Demyelinating Polyneuropathy in a Patient With Decompensated Alcohol-Induced Cirrhosis. Cureus 2020. [DOI: 10.7759/cureus.11281] [Reference Citation Analysis]
79 Khaja M, Gomez GPR, Santana Y, Hernandez N, Haider A, Lara JLP, Elkin R. A 44-Year-Old Hispanic Man with Loss of Taste and Bilateral Facial Weakness Diagnosed with Guillain-Barré Syndrome and Bell's Palsy Associated with SARS-CoV-2 Infection Treated with Intravenous Immunoglobulin. Am J Case Rep 2020;21:e927956. [PMID: 33128540 DOI: 10.12659/AJCR.927956] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 6.7] [Reference Citation Analysis]
80 Al-attas A, Aldayel A, Al najjar S, Alkhonezan S. Guillain-Barré Syndrome Heralding the Diagnosis of Hodgkin Lymphoma: A Case Report. Case Rep Neurol 2020;12:365-372. [DOI: 10.1159/000509681] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
81 Kazamel M, Desnick RJ, Quigley JG. Porphyric Neuropathy: Pathophysiology, Diagnosis, and Updated Management. Curr Neurol Neurosci Rep 2020;20:56. [PMID: 33026560 DOI: 10.1007/s11910-020-01078-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
82 Kofahi R, Aldabbour B, Aljezawi M. <p>A Rare Case with New Insights: Pure Sensory Guillain Barre Syndrome with Axonal Features</p>. IMCRJ 2020;Volume 13:543-549. [DOI: 10.2147/imcrj.s280255] [Reference Citation Analysis]
83 Rezaee S, Mazdeh M, Behzad M, Zamani A, Eftekharian MM, MSc in Immunology, Hamadan University of Medical Sciences, Hamadan, Iran, Professor, Departement of Neurology, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran, Associate Professor, Departement of Immunology, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran, Professor, Departement of Immunology, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran, Associate Professor, Departement of Immunology, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran. Interleukin-34 Gene Expression in the Peripheral Blood Leukocytes of Guillain-Barre Patients. Avicenna J Clin Med 2020;27:77-84. [DOI: 10.29252/ajcm.27.2.77] [Reference Citation Analysis]
84 TunÇ A, TekeŞİn A, GÜzel V, ÜnlÜbaŞ Y, SeferoĞlu M. The prognostic value of demyelinating electrophysiologic findings and cerebrospinal fluid protein levels in acute inflammatory demyelinating polyneuropathy. Arq Neuropsiquiatr 2020;78:481-7. [PMID: 32844898 DOI: 10.1590/0004-282x20200042] [Reference Citation Analysis]
85 Beaver JT, Mills LK, Swieboda D, Lelutiu N, Esser ES, Antao OQ, Scountzou E, Williams DT, Papaioannou N, Littauer EQ, Romanyuk A, Compans RW, Prausnitz MR, Skountzou I. Cutaneous vaccination ameliorates Zika virus-induced neuro-ocular pathology via reduction of anti-ganglioside antibodies. Hum Vaccin Immunother 2020;16:2072-91. [PMID: 32758106 DOI: 10.1080/21645515.2020.1775460] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
86 Beaver JT, Mills LK, Swieboda D, Lelutiu N, Esser ES, Antao OQ, Scountzou E, Williams DT, Papaioannou N, Littauer EQ, Skountzou I. Zika virus-induced neuro-ocular pathology in immunocompetent mice correlates with anti-ganglioside autoantibodies. Hum Vaccin Immunother 2020;16:2092-108. [PMID: 32758108 DOI: 10.1080/21645515.2020.1775459] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
87 Talmage JB, Hyman MH, Snyder RB. Rating Survivors of COVID-19 for Permanent Impairment. Guides Newsletter 2020;25:3-7. [DOI: 10.1001/amaguidesnewsletters.2020.julaug01] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
88 Hyman MH, Talmage JB, Hegmann KT. Evaluating Covid-19 Injury Claims With a Focus on Workers’ Compensation. Journal of Occupational & Environmental Medicine 2020;62:692-9. [DOI: 10.1097/jom.0000000000001950] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
89 Algahtani H, Shirah B, Alrefaei K, Albassam M, Abdelghaffar N. Are Repeated Cycles of Intravenous Immunoglobulin Justified in Patients With Poorly Responsive Guillain-Barré Syndrome? Neurohospitalist 2020;10:224-8. [PMID: 32549948 DOI: 10.1177/1941874419893570] [Reference Citation Analysis]
90 Jia L, Zhang H. Comment on “Guillain-Barré syndrome as a complication of hypertensive basal ganglia haemorrhage.”. Journal of Clinical Neuroscience 2020;76:259-260. [DOI: 10.1016/j.jocn.2020.04.019] [Reference Citation Analysis]
91 Pérez Sánchez S, Pérez Noguera R, Sánchez Sánchez V, López Domínguez J. Anti-Hu associated paraneoplastic neuropathy simulating an axonal variant of Guillain-Barré syndrome. Neurología (English Edition) 2020;35:346-347. [DOI: 10.1016/j.nrleng.2017.09.014] [Reference Citation Analysis]
92 Juliao Caamaño DS, Alonso Beato R. Facial diplegia, a possible atypical variant of Guillain-Barré Syndrome as a rare neurological complication of SARS-CoV-2. J Clin Neurosci 2020;77:230-2. [PMID: 32410788 DOI: 10.1016/j.jocn.2020.05.016] [Cited by in Crossref: 85] [Cited by in F6Publishing: 92] [Article Influence: 28.3] [Reference Citation Analysis]
93 Jia L, Zhang H. Hypoalbuminemia in Guillain-Barré syndrome. J Clin Neurosci 2020;77:249-50. [PMID: 32362470 DOI: 10.1016/j.jocn.2020.04.105] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
94 Berisavac I, Arsenijevic M, Bozovic I, Mladenovic B, Kacar A, Stojiljkovic Tamas O, Petrovic M, Stojanovic M, Vujovic B, Martic V, Jovanovic D, Lavrnic D, Basta I, Peric S. Disability and quality of life in Guillain-Barré syndrome - Longitudinal study. J Clin Neurosci 2020;78:185-8. [PMID: 32334960 DOI: 10.1016/j.jocn.2020.04.076] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
95 Abhinav G, Gamez J Jr, Yang MC, Vaysman T, von Gunten M, Liu A. Faster Recovery of Internal Ophthalmoplegia than External Ophthalmoplegia in a Miller Fisher Variant of Guillain-Barre Syndrome. Case Rep Ophthalmol Med 2020;2020:7258327. [PMID: 32328331 DOI: 10.1155/2020/7258327] [Reference Citation Analysis]
96 Arora A, Shere A, Patel K, Gunawardhana N, LiFuentes E. A Rare Case of Autoimmune Demyelinating Polyneuropathy and Hydrocephalus Secondary to Pembrolizumab. J Investig Med High Impact Case Rep 2020;8:2324709620916358. [PMID: 32321302 DOI: 10.1177/2324709620916358] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
97 Finneran MM, Gaynor B, Omi E. Guillain-Barré Syndrome After a Gunshot Wound to the Thoracic Spine. World Neurosurg 2020;139:175-8. [PMID: 32311568 DOI: 10.1016/j.wneu.2020.04.054] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
98 Bao L, Chen X, Li Q, Zhang R, Shi H, Cui G. Surgery and Guillain-Barré Syndrome: A Single-Center Retrospective Study Focused on Clinical and Electrophysiological Subtypes. Neuropsychiatr Dis Treat 2020;16:969-74. [PMID: 32346291 DOI: 10.2147/NDT.S241128] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
99 Wei CW, Liu CY, Chang CY, Liu WC, Cheng HC, Tung HH, Chiang NC, Chang HH. Guillain-Barré syndrome in a heart transplantation recipient. J Am Assoc Nurse Pract 2020;33:639-45. [PMID: 32282569 DOI: 10.1097/JXX.0000000000000400] [Reference Citation Analysis]
100 Dardiotis E, Sokratous M, Tsouris Z, Siokas V, Mentis AA, Aloizou A, Michalopoulou A, Bogdanos DP, Xiromerisiou G, Deretzi G, Kountouras J, Hadjigeorgiou GM. Association between Helicobacter py lori infection and Guillain‐Barré Syndrome: A meta‐analysis. Eur J Clin Invest 2020;50. [DOI: 10.1111/eci.13218] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
101 Ashrafi MR, Mohammadalipoor A, Naeini AR, Amanat M, Tavasoli AR, Heidari M, Badv RS, Mohammadi M, Zamani GR, Rahimi-Dehgolan S, Rahimi R, Akbari MG. Clinical Characteristics and Electrodiagnostic Features of Guillain-Barré Syndrome Among the Pediatric Population. J Child Neurol 2020;35:448-55. [PMID: 32156188 DOI: 10.1177/0883073820905157] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
102 Shang P, Zhu M, Wang Y, Zheng X, Wu X, Zhu J, Feng J, Zhang HL. Axonal variants of Guillain-Barré syndrome: an update. J Neurol 2021;268:2402-19. [PMID: 32140865 DOI: 10.1007/s00415-020-09742-2] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 6.0] [Reference Citation Analysis]
103 Djordjevic G, Stojanov A, Bozovic I, Berisavac I, Arsenijevic M, Lukic Rajic S, Dominovic Kovacevic A, Jovanovic D, Basta I, Peric S. Six-month prospective study of quality of life in Guillain-Barre syndrome. Acta Neurol Scand 2020;141:236-41. [PMID: 31705530 DOI: 10.1111/ane.13195] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
104 Silva MA, Palacios E, Castillo GA, Monsalve JA, Leal Castaño LF. Secuelas neurológicas del síndrome de Guillain-Barré en pacientes adultos. Repert Med Cir 2020;29:185-191. [DOI: 10.31260/repertmedcir.01217273.972] [Reference Citation Analysis]
105 Al hamdani S, Aljanabi F, Abdulrasool M, Salman A. Child with Guillain-Barré Syndrome Responding to Plasmapheresis: A Case Report. Case Rep Acute Med 2020;3:4-11. [DOI: 10.1159/000505964] [Reference Citation Analysis]
106 Wanleenuwat P, Iwanowski P, Kozubski W. Antiganglioside antibodies in neurological diseases. Journal of the Neurological Sciences 2020;408:116576. [DOI: 10.1016/j.jns.2019.116576] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
107 Eastlack S, Armstead-williams C, Bailey CH, Trosclair L, Hyatali F, Patil S, Siddaiah H, Senthil A, Mouhaffel A, Cornett EM, Kaye AD. Patient with Guillain Barre Syndrome (GBS). Guide to the Inpatient Pain Consult 2020. [DOI: 10.1007/978-3-030-40449-9_26] [Reference Citation Analysis]
108 Salih MAM, Azzedine H. Peripheral Nerve Disorders. Clinical Child Neurology 2020. [DOI: 10.1007/978-3-319-43153-6_41] [Reference Citation Analysis]
109 Babazadeh A, Mohseni Afshar Z, Javanian M, Mohammadnia-Afrouzi M, Karkhah A, Masrour-Roudsari J, Sabbagh P, Koppolu V, Vasigala VK, Ebrahimpour S. Influenza Vaccination and Guillain-Barré Syndrome: Reality or Fear. J Transl Int Med 2019;7:137-42. [PMID: 32010599 DOI: 10.2478/jtim-2019-0028] [Cited by in Crossref: 16] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
110 Feinisa Khairani A, Karina M, Hanum Siswanti L, Milanti Dewi M. Clinical Profile of Pediatric Guillain-Barré Syndrome: A study from National Referral Hospital in West Java, Indonesia. Biomed Pharmacol J 2019;12:2043-8. [DOI: 10.13005/bpj/1837] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
111 Bazaraa HM, Rady HI, Mohamed SA, Rabie WA, ElAnwar NH. Initial Response and Outcome of Critically Ill Children With Guillain Barre' Syndrome. Front Pediatr 2019;7:378. [PMID: 31620410 DOI: 10.3389/fped.2019.00378] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
112 Millán S, Díaz C, David Pardo DG, Castro Guzmán G. Clinical and neurophysiological characteristics of patients with Guillain-Barré syndrome at Hospital Universitario San Ignacio, Bogotá, Colombia between 2009 and 2017. J Peripher Nerv Syst 2019;24:272-5. [PMID: 31410933 DOI: 10.1111/jns.12345] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
113 Samadi A, Mansour-Ghanaei F, Joukar F, Mavaddati S, Sufi Afshar I. A 30-Year-Old Man with Acute Motor Axonal Neuropathy Subtype of Guillain-Barré Syndrome Having Hepatitis A Virus Infection. Middle East J Dig Dis 2019;11:110-5. [PMID: 31380008 DOI: 10.15171/mejdd.2018.136] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
114 Vitiello G, Emmi G, Silvestri E, Di Scala G, Palterer B, Parronchi P. Intravenous immunoglobulin therapy: a snapshot for the internist. Intern Emerg Med 2019;14:1041-9. [PMID: 31309519 DOI: 10.1007/s11739-019-02150-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
115 Staszel JP, Miknevich M. Not Always as It Seems: A Case of Ascending Paralysis. Am J Phys Med Rehabil 2020;99:e32-4. [PMID: 31205060 DOI: 10.1097/PHM.0000000000001244] [Reference Citation Analysis]
116 Shreve M, Jarrett A, Scott AL, Mcneill C. Zika: An Unfolding Story. The Journal for Nurse Practitioners 2019;15:410-414.e2. [DOI: 10.1016/j.nurpra.2018.11.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
117 Elettreby MF, Ahmed E, Safan M. A simple mathematical model for Guillain–Barré syndrome. Adv Differ Equ 2019;2019. [DOI: 10.1186/s13662-019-2146-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
118 A. Synopsis of Neurology, Psychiatry and Related Systemic Disorders 2019. [DOI: 10.1017/9781107706866.001] [Reference Citation Analysis]
119 Ho S, Liu A. A Co-Occurrence of Serologically Proven Myasthenia Gravis and Pharyngeal-Cervical-Brachial Variant of Guillain-Barré Syndrome. Case Rep Neurol Med 2019;2019:4695010. [PMID: 31080681 DOI: 10.1155/2019/4695010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
120 Hess SR, Waligora AC, Jiranek WA, Golladay GJ. Inflammatory demyelinating polyneuropathy after total hip arthroplasty. Arthroplast Today 2019;5:17-20. [PMID: 31020015 DOI: 10.1016/j.artd.2018.08.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
121 Hameed S, Khan S. Rare variant of Guillain-Barré syndrome after chikungunya viral fever. BMJ Case Rep 2019;12:e228845. [PMID: 31015248 DOI: 10.1136/bcr-2018-228845] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
122 de Castillo LLC, Diestro JDB, Ignacio KHD, Pasco PMD. A rare mimic of acute stroke: rapidly progressing Miller-Fisher Syndrome to acute motor and sensory axonal neuropathy variant of Guillain-Barre Syndrome. BMJ Case Rep 2019;12:e228220. [PMID: 30936342 DOI: 10.1136/bcr-2018-228220] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
123 Asiri S, Altwaijri WA, Ba-Armah D, Al Rumayyan A, Alrifai MT, Salam M, Almutairi AF. Prevalence and outcomes of Guillain-Barré syndrome among pediatrics in Saudi Arabia: a 10-year retrospective study. Neuropsychiatr Dis Treat 2019;15:627-35. [PMID: 30880987 DOI: 10.2147/NDT.S187994] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
124 Leitzen E, Raddatz BB, Jin W, Goebbels S, Nave KA, Baumgärtner W, Hansmann F. Virus-triggered spinal cord demyelination is followed by a peripheral neuropathy resembling features of Guillain-Barré Syndrome. Sci Rep 2019;9:4588. [PMID: 30872675 DOI: 10.1038/s41598-019-40964-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
125 Barrell K, Smith AG. Peripheral Neuropathy. Medical Clinics of North America 2019;103:383-97. [DOI: 10.1016/j.mcna.2018.10.006] [Cited by in Crossref: 50] [Cited by in F6Publishing: 38] [Article Influence: 12.5] [Reference Citation Analysis]
126 Park SJ, Kim JK, Kim HH, Yoon BA, Ji DY, Lee CW, Kim HJ, Kim KH, Shin HY, Park SJ, Lee DY. Integrative metabolomics reveals unique metabolic traits in Guillain-Barré Syndrome and its variants. Sci Rep 2019;9:1077. [PMID: 30705347 DOI: 10.1038/s41598-018-37572-w] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
127 Rafanelli M, Walsh K, Hamdan MH, Buyan-Dent L. Autonomic dysfunction: Diagnosis and management. Handb Clin Neurol 2019;167:123-37. [PMID: 31753129 DOI: 10.1016/B978-0-12-804766-8.00008-X] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
128 Farin CV, Luedke MW. Neurologic Complications after Kidney Transplantation. Kidney Transplantation - Principles and Practice 2019. [DOI: 10.1016/b978-0-323-53186-3.00033-4] [Reference Citation Analysis]
129 Sajan A, Zahid S, Stumph J, Griepp D, Saba S, Ilyas N, McFarlane IM. A Rare Case of HIV-Induced Inflammatory Demyelinating Polyneuropathy. Am J Med Case Rep 2019;7:5-8. [PMID: 30899779 DOI: 10.12691/ajmcr-7-1-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
130 Bril EV, Popugaev KA, Udalov YD, Parinov OV, Zabelin MV, Samoilov AS. Critical Care Management of Guillain-Barré Syndrome. Textbook of Neuroanesthesia and Neurocritical Care 2019. [DOI: 10.1007/978-981-13-3390-3_4] [Reference Citation Analysis]
131 Dodson SC, Koontz NA. Spinal Manifestations of Systemic Disease. Radiol Clin North Am 2019;57:281-306. [PMID: 30709471 DOI: 10.1016/j.rcl.2018.10.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
132 Schröder JB, Marian T, Muhle P, Claus I, Thomas C, Ruck T, Wiendl H, Warnecke T, Suntrup-Krueger S, Meuth S, Dziewas R. Intubation, tracheostomy, and decannulation in patients with Guillain-Barré-syndrome-does dysphagia matter? Muscle Nerve 2019;59:194-200. [PMID: 30390307 DOI: 10.1002/mus.26377] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
133 Bong-yeon Lee, Su-ra Ryu, Yu-ri Choe, Seo-ra Yoon. Guillain-Barre Syndrome after Minimally Invasive Lumbar Procedure: A Case Report. jouranlofkoreanassociationofemgelectrodiagnosticmedicine 2018;20:159-163. [DOI: 10.18214/jkaem.2018.20.2.159] [Reference Citation Analysis]
134 Streckmann F, Balke M. Bewegungstherapie bei Polyneuropathie. Diabetologe 2018;14:605-617. [DOI: 10.1007/s11428-018-0426-8] [Reference Citation Analysis]
135 Bauer Z, Eum KS, Ji J, Bunin J, Sherratt J. Clinical Reasoning: A 35-year-old woman with diplopia, ataxia, and altered mental status. Neurology 2018;91:e1942-6. [PMID: 30420464 DOI: 10.1212/WNL.0000000000006499] [Reference Citation Analysis]
136 Beattie J, Parajuli S, Sanger M, Lee G, Pleninger P, Crowley G, Kwon S, Murthy V, Manko JA, Caplan A, Dufort E, Pastula DM, Nolan A. Zika Virus-Associated Guillain-Barré Syndrome in a Returning US Traveler. Infect Dis Clin Pract (Baltim Md) 2018;26:e80-4. [PMID: 30923438 DOI: 10.1097/IPC.0000000000000654] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
137 Lombardi E, Misek R, Patel K. An Unusual Presentation of Acute Weakness: Acute Inflammatory Demyelinating Polyneuropathy in a Patient with Psychiatric Illness. Case Rep Emerg Med 2018;2018:4065342. [PMID: 30345121 DOI: 10.1155/2018/4065342] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
138 Vargas Rodríguez LJ, Agudelo Sanabria MB, Márquez Rosales BA, Rozo Ortiz EJ, Vega Sepúlveda AC. Síndrome de Guillain Barré de variante descendente asociado a infección por chikungunya. Neurología Argentina 2018;10:241-244. [DOI: 10.1016/j.neuarg.2018.03.001] [Reference Citation Analysis]
139 Debnath M, Nagappa M, Subbanna M, Sundaravadivel P, Talukdar PM, Shivakumar V, Wahatule R, Dutta D, Binukumar B, Sinha S, Bindu PS, Periyavan S, Umamaheswara Rao G, Taly AB. Th17 pathway signatures in a large Indian cohort of Guillain Barré syndrome. Journal of Neuroimmunology 2018;323:125-30. [DOI: 10.1016/j.jneuroim.2018.08.001] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
140 Güzey Aras Y, Doğan Güngen B. Seasonal characteristics and clinical treatment in the Guillaine-Barré syndrome 63 evaluation of the patient series. Ortadogu Tıp Derg 2018;10:284-288. [DOI: 10.21601/ortadogutipdergisi.332864] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
141 Streckmann F, Balke M. Bewegungstherapie bei Polyneuropathie. DGNeurologie 2018;1:47-57. [DOI: 10.1007/s42451-018-0010-x] [Cited by in Crossref: 2] [Article Influence: 0.4] [Reference Citation Analysis]
142 Zhao PP, Ji QK, Sui RB, Zhang R, Zhang LJ, Xu ZX, Li Q, Ji SB, Zhao JH. Increased intracranial pressure in Guillain-Barré syndrome: A case report. Medicine (Baltimore) 2018;97:e11584. [PMID: 30045288 DOI: 10.1097/MD.0000000000011584] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
143 Durcan R, Murphy O, Reid V, Lynch T. Guillain-Barré syndrome mimicking botulism in early disease course. Pract Neurol 2018;18:501-4. [PMID: 30061335 DOI: 10.1136/practneurol-2018-001891] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
144 Azevedo MB, Coutinho MSC, Silva MAD, Arduini DB, Lima JDV, Monteiro R, Mendes BNB, Lemos MCF, Noronha CP, Saraceni V. Neurologic manifestations in emerging arboviral diseases in Rio de Janeiro City, Brazil, 2015-2016. Rev Soc Bras Med Trop 2018;51:347-51. [PMID: 29972566 DOI: 10.1590/0037-8682-0327-2017] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
145 Taha T, Tzuk-Shina T, Forschner I, Bar-Sela G. Acute motor and sensory axonal neuropathy related to treatment with MEK inhibitors in a patient with advanced melanoma. Melanoma Res 2017;27:632-4. [PMID: 28872488 DOI: 10.1097/CMR.0000000000000390] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
146 Chae CS, Kwon KM, Lee JS, Kim YH. A Case Report of Overlapping Miller Fisher Syndrome, Guillain-Barré Syndrome, and the Bickerstaff Brainstem Encephalitis. The Neurologist 2018;23:128-30. [DOI: 10.1097/nrl.0000000000000183] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
147 Ehler E. Focal forms of acute polyradiculoneuritis. Neurol pro Praxi 2018;19:183-186. [DOI: 10.36290/neu.2018.094] [Reference Citation Analysis]
148 Ancona P, Bailey M, Bellomo R. Characteristics, incidence and outcome of patients admitted to intensive care unit with Guillain-Barre syndrome in Australia and New Zealand. Journal of Critical Care 2018;45:58-64. [DOI: 10.1016/j.jcrc.2018.01.016] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
149 Bido-Medina R, Wirsich J, Rodríguez M, Oviedo J, Miches I, Bido P, Tusen L, Stoeter P, Sadaghiani S. Impact of Zika Virus on adult human brain structure and functional organization. Ann Clin Transl Neurol 2018;5:752-62. [PMID: 29928658 DOI: 10.1002/acn3.575] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
150 Martic V, Bozovic I, Berisavac I, Basta I, Peric S, Babic M, Rajic SL, Bjelica B, Stojiljkovic Tamas O, Stojanov A, Grunauer M, Cobeljic M, Komatina N, Djuric V, Petrovic M, Vujovic B, Dominovic Kovacevic A, Djordjevic G, Jovanovic D, Stevic Z. Three-Year Follow-Up Study in Patients with Guillain-Barré Syndrome. Can J Neurol Sci 2018;45:269-74. [DOI: 10.1017/cjn.2018.12] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
151 Restrepo-jiménez P, Rodríguez Y, González P, Chang C, Gershwin ME, Anaya J. The immunotherapy of Guillain-Barré syndrome. Expert Opinion on Biological Therapy 2018;18:619-31. [DOI: 10.1080/14712598.2018.1468885] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
152 Silva CAM, Belisle JT. Host Lipid Mediators in Leprosy: The Hypothesized Contributions to Pathogenesis. Front Immunol 2018;9:134. [PMID: 29472920 DOI: 10.3389/fimmu.2018.00134] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
153 Halstead SB. Chikungunya and Zika Disease. Chikungunya and Zika Viruses 2018. [DOI: 10.1016/b978-0-12-811865-8.00003-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
154 Da Silva MG, Albiol-pérez S, Lombano JL, Salas SV, Cano S, Gutierrez EG, Jacho-guanoluisa N, Collazos CA. A Groundbreaking Technology in Virtual Rehabilitation to Improve Falls in Older People. Advances in Intelligent Systems and Computing 2018. [DOI: 10.1007/978-3-319-77712-2_120] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
155 Pérez Sánchez S, Pérez Noguera R, Sánchez Sánchez V, López Domínguez JM. Anti-Hu associated paraneoplastic neuropathy simulating an axonal variant of Guillain-Barré syndrome. Neurologia (Engl Ed) 2020;35:346-7. [PMID: 29169808 DOI: 10.1016/j.nrl.2017.09.006] [Reference Citation Analysis]
156 Vasconcelos MM, Vasconcelos LG, Brito AR. Assessment of acute motor deficit in the pediatric emergency room. Jornal de Pediatria (Versão em Português) 2017;93:26-35. [DOI: 10.1016/j.jpedp.2017.08.008] [Reference Citation Analysis]
157 Vasconcelos MM, Vasconcelos LG, Brito AR. Assessment of acute motor deficit in the pediatric emergency room. Jornal de Pediatria 2017;93:26-35. [DOI: 10.1016/j.jped.2017.06.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
158 Mengi T, Seçil Y, İncesu TK, Arici Ş, Akkiraz ZÖ, Gürgör N, Gedizlioğlu M, Ertekin C. Guillain–Barré Syndrome and Swallowing Dysfunction: . Journal of Clinical Neurophysiology 2017;34:393-9. [DOI: 10.1097/wnp.0000000000000380] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
159 Panosyan FB. Bilateral Ptosis due to Sympathetic Dysfunction as a Feature of Guillain-Barre Syndrome. Journal of Clinical Neuromuscular Disease 2017;19:38-42. [DOI: 10.1097/cnd.0000000000000163] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
160 Patel P, Kearney JF. Immunological Outcomes of Antibody Binding to Glycans Shared between Microorganisms and Mammals. J Immunol 2016;197:4201-9. [PMID: 27864551 DOI: 10.4049/jimmunol.1600872] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]
161 Yang L, Wu EY, Tarrant TK. Immune Gamma Globulin Therapeutic Indications in Immune Deficiency and Autoimmunity. Curr Allergy Asthma Rep 2016;16:55. [PMID: 27401913 DOI: 10.1007/s11882-016-0632-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
162 Nayak R. Practical approach to the patient with acute neuromuscular weakness. World J Clin Cases 2017; 5(7): 270-279 [PMID: 28798922 DOI: 10.12998/wjcc.v5.i7.270] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
163 Patwala K, Crump N, De Cruz P. Guillain-Barré syndrome in association with antitumour necrosis factor therapy: a case of mistaken identity. BMJ Case Rep 2017;2017:bcr-2017-219481. [PMID: 28679512 DOI: 10.1136/bcr-2017-219481] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
164 Lomaglio M, Canale B. Differential diagnosis and recovery of acute bilateral foot drop in a patient with a history of low back pain: A case report. Physiother Theory Pract 2017;33:508-14. [PMID: 28509608 DOI: 10.1080/09593985.2017.1323358] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
165 Duffy SS, Keating BA, Perera CJ, Moalem-taylor G. The role of regulatory T cells in nervous system pathologies. J Neuro Res 2018;96:951-68. [DOI: 10.1002/jnr.24073] [Cited by in Crossref: 43] [Cited by in F6Publishing: 46] [Article Influence: 7.2] [Reference Citation Analysis]
166 Zhang L, Guo H, Zhang D, Wang R, Li T, Li L, Suo D, Yang L. Analysis of serum interleukin-27 and interleukin-35 concentrations in patients with Guillain-Barré syndrome. Clinica Chimica Acta 2017;468:5-9. [DOI: 10.1016/j.cca.2017.02.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
167 Löscher W, Iglseder B. [Polyneuropathy in the elderly]. Z Gerontol Geriatr 2017;50:347-61. [PMID: 28455594 DOI: 10.1007/s00391-017-1233-3] [Cited by in Crossref: 4] [Article Influence: 0.7] [Reference Citation Analysis]
168 Slingerland AE, Schwabkey Z, Wiesnoski DH, Jenq RR. Clinical Evidence for the Microbiome in Inflammatory Diseases. Front Immunol 2017;8:400. [PMID: 28446909 DOI: 10.3389/fimmu.2017.00400] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 5.8] [Reference Citation Analysis]
169 Pinto-Díaz CA, Rodríguez Y, Monsalve DM, Acosta-Ampudia Y, Molano-González N, Anaya JM, Ramírez-Santana C. Autoimmunity in Guillain-Barré syndrome associated with Zika virus infection and beyond. Autoimmun Rev 2017;16:327-34. [PMID: 28216074 DOI: 10.1016/j.autrev.2017.02.002] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 4.8] [Reference Citation Analysis]
170 Shin SK, Kim KO, Kim EJ, Kim SY, Kim JH, Kim YJ, Chung JW, Kwon KA, Park DK. Peroral endoscopic myotomy for treatment of Guillain-Barre syndrome-associated achalasia: A rare case. World J Gastroenterol 2017; 23(5): 926-930 [PMID: 28223738 DOI: 10.3748/wjg.v23.i5.926] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
171 Shubhakaran K. Cranial nerve involvement in Guillain–Barre syndrome: Revisited. J Pediatr Neurosci 2017;12:398. [DOI: 10.4103/jpn.jpn_18_17] [Reference Citation Analysis]
172 Bordini BJ, Monrad P. Differentiating Familial Neuropathies from Guillain-Barré Syndrome. Pediatr Clin North Am 2017;64:231-52. [PMID: 27894447 DOI: 10.1016/j.pcl.2016.08.015] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
173 Gross S, Fischer A, Rosati M, Matiasek L, Corlazzoli D, Cappello R, Porcarelli L, Harcourt-Brown T, Jurina K, Garosi L, Flegel T, Quitt P, Molin J, Huelsmeyer VI, Schenk H, Gandini G, Gnirs K, Blot S, Jeandel A, Baroni M, Loderstedt S, Abbiati G, Leithaeuser C, Schulze S, Kornberg M, Lowrie M, Matiasek K. Nodo-paranodopathy, internodopathy and cleftopathy: Target-based reclassification of Guillain-Barré-like immune-mediated polyradiculoneuropathies in dogs and cats. Neuromuscul Disord 2016;26:825-36. [PMID: 27743643 DOI: 10.1016/j.nmd.2016.08.015] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
174 Pastula DM, Khan AS, Sharp TM, Biaukula VL, Naivalu TK, Rafai E, Ermias Belay, Staples JE, Fischer M, Kosoy OI, Laven JJ, Bennett EJ, Jenney AWJ, Naidu RN, Lanciotti RS, Galloway RL, Nilles EJ, Sejvar JJ, Kama M. Investigation of a Guillain-Barré syndrome cluster in the Republic of Fiji. J Neurol Sci 2017;372:350-5. [PMID: 27842986 DOI: 10.1016/j.jns.2016.08.064] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
175 Sinmaz N, Nguyen T, Tea F, Dale RC, Brilot F. Mapping autoantigen epitopes: molecular insights into autoantibody-associated disorders of the nervous system. J Neuroinflammation 2016;13:219. [PMID: 27577085 DOI: 10.1186/s12974-016-0678-4] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 4.3] [Reference Citation Analysis]
176 Divecha C, Tullu MS, Gandhi A, Deshmukh CT. Acute intermittent porphyria: A critical diagnosis for favorable outcome. Indian J Crit Care Med 2016;20:428-31. [PMID: 27555700 DOI: 10.4103/0972-5229.186262] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
177 Han TH, Kim DY, Park DW, Moon JH. Transient Isolated Lower Bulbar Palsy With Elevated Serum Anti-GM1 and Anti-GD1b Antibodies During Aripiprazole Treatment. Pediatr Neurol 2017;66:96-9. [PMID: 28341090 DOI: 10.1016/j.pediatrneurol.2016.07.011] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
178 Olive G, Clarke A, Doerholt K, Gowda V, Siddiqui A, Lim MJ. Acute flaccid weakness with myelopathy and peripheral nerve involvement in 2 children: Recent characterization of a previously observed phenomenon. Eur J Paediatr Neurol 2016;20:948-52. [PMID: 27452920 DOI: 10.1016/j.ejpn.2016.07.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
179 Saxena A. Probiotics as a Potential Alternative for Relieving Peripheral Neuropathies: a Case for Guillain-Barré Syndrome. Front Microbiol 2015;6:1497. [PMID: 26779152 DOI: 10.3389/fmicb.2015.01497] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
180 Liao B, Kamiya-Matsuoka C, Fang X, Smith RG, Shanina E. Alternating ptosis associated with asialo-GM1 and GD1b antibodies. Int J Neurosci 2016;126:1139-41. [PMID: 26710925 DOI: 10.3109/00207454.2015.1136825] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
181 Hernández-beltrán N, Rodríguez Quintana J, Mantilla Sylvain F. Síndrome de Guillain-Barré en un paciente con enfermedad de Chagas aguda. Infectio 2015;19:172-174. [DOI: 10.1016/j.infect.2015.01.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
182 Dubey D, Kapotic M, Freeman M, Sawhney A, Rojas JC, Warnack W, Vernino S. Factors contributing to delay in diagnosis of Guillain-Barré syndrome and impact on clinical outcome. Muscle Nerve 2016;53:384-7. [PMID: 26185107 DOI: 10.1002/mus.24772] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
183 Estridge R, Iskander M. Understanding Guillain-Barré syndrome. Journal of the American Academy of Physician Assistants 2015;28:19-22. [DOI: 10.1097/01.jaa.0000466585.10595.f5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
184 Dimachkie MM, Saperstein DS. Acquired immune demyelinating neuropathies. Continuum (Minneap Minn) 2014;20:1241-60. [PMID: 25299280 DOI: 10.1212/01.CON.0000455883.91426.12] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
185 Stoll SS, Rakocevic G. Severe Acute Inflammatory Demyelinating Polyradiculoneuropathy With Persistent Weakness Associated With Tumor-Like Nerve Root Enlargement. Journal of Clinical Neuromuscular Disease 2015;16:220-2. [DOI: 10.1097/cnd.0000000000000076] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
186 Pasanen ME. Guillain-Barré Syndrome. Hospital Medicine Clinics 2015;4:177-190. [DOI: 10.1016/j.ehmc.2014.12.005] [Reference Citation Analysis]
187 Albiol-Pérez S, Forcano-García M, Muñoz-Tomás MT, Manzano-Fernández P, Solsona-Hernández S, Mashat MA, Gil-Gómez JA. A novel virtual motor rehabilitation system for Guillain-Barré syndrome. Two single case studies. Methods Inf Med 2015;54:127-34. [PMID: 25609504 DOI: 10.3414/ME14-02-0002] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
188 Dimachkie MM, Barohn RJ. Peripheral Neuropathies. Nerves and Nerve Injuries 2015. [DOI: 10.1016/b978-0-12-802653-3.00104-4] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
189 Hoyos Gutiérrez JB, Universidad Militar Nueva Granada, Leal Arenas FA, Antolinez AM, Instituto Nacional de Cancerología, Instituto Nacional de Cancerología. El dolor en el síndrome de Guillain - Barré ¿un síntoma subtratado? Rev Col Med Fis Reh 2015;25:156-162. [DOI: 10.28957/rcmfr.v25n2a7] [Reference Citation Analysis]
190 Ye Y, Li S, Li Y. Comparison on therapeutic effect of plasma exchange and intravenous immunoglobulin for Guillian-Barre syndrome: Comparison of PE and IVIg for GBS. Transfusion Med 2015;25:79-84. [DOI: 10.1111/tme.12169] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
191 최혜정, 이중훈. Guillain-Barre Syndrome Sensory Variant Mimicking Diabetic Peripheral Neuropathy - A Case Report -. jouranlofkoreanassociationofemgelectrodiagnosticmedicine 2014;16:85-88. [DOI: 10.18214/jkaem.2014.16.2.85] [Reference Citation Analysis]
192 Watanabe T. Kawasaki Disease with Retropharyngeal Edema following a Blackfly Bite. Case Rep Pediatr 2014;2014:296456. [PMID: 25349761 DOI: 10.1155/2014/296456] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
193 Sim GY, Kim WS. Clinical variants of Guillain-Barré syndrome in children. J Biomed Res 2014;15:141-145. [DOI: 10.12729/jbr.2014.15.3.141] [Reference Citation Analysis]
194 Morgan ML, Law N, Espino Barros Palau A, Saeed U, Yalmanchili S, Lee AG. Anti-asialo-GM1 and GD1a variant of Miller Fisher variant of Guillain-Barré Syndrome. J Neuroophthalmol 2014;34:377-9. [PMID: 25062498 DOI: 10.1097/WNO.0000000000000156] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
195 Barohn RJ, Amato AA. Pattern-recognition approach to neuropathy and neuronopathy. Neurol Clin 2013;31:343-61. [PMID: 23642713 DOI: 10.1016/j.ncl.2013.02.001] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 3.8] [Reference Citation Analysis]